Scientists have developed a new cell therapy for chronic inflammatory conditions such as Crohn’s disease. Patient’s own blood cells are used to produce a type of cell — Type 1 T regulatory lymphocyte — that can reduce the extent of the disease.
Scientists have developed a new cell therapy for chronic inflammatory conditions such as Crohn’s disease. Patient’s own blood cells are used to produce a type of cell — Type 1 T regulatory lymphocyte — that can reduce the extent of the disease.